CSL publishes swine influenza vaccine data

CSL Ltd. (ASX:CSL) said preliminary data from a Phase II trial of its unadjuvanted monovalent vaccine against swine influenza A (H1N1) demonstrated a "robust immune response" in healthy adults after a...